Vanguard Capital Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.2M Sell
537,567
-15,435
-3% -$1.42M ﹤0.01% 1985
2026
Q2
$56.9M Sell
553,002
-20,845
-4% -$1.22M ﹤0.01% 1867
2026
Q1
$21.9M Buy
+573,847
New +$18.2M ﹤0.01% 2293

Other funds holding ATEX

Vanguard Capital Management's ATEX Position: Q3 2026 in Review

Vanguard Capital Management reduced its Anterix (ATEX) stake by 2.8% in Q3 2026, selling an estimated $1.42M and leaving 537,567 shares worth $42.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1985.

Vanguard Capital Management first reported a position in ATEX in Q1 2026 and has held it in 3 quarters since. The position peaked at $56.9M in Q2 2026. 178 funds tracked by Wall St. Rank hold ATEX as of Q3 2026.

  • Vanguard Capital Management held 537,567 shares of Anterix worth $42.2M as of Q3 2026.
  • Vanguard Capital Management sold 15,435 Anterix shares in Q3 2026, an estimated $1.42M.
  • Anterix made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1985 holding.
  • Vanguard Capital Management first reported a position in Anterix in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Anterix position peaked at $56.9M in Q2 2026.
  • 178 funds tracked by Wall St. Rank held Anterix as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.